These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33652135)

  • 1. Asthma Patients Who Stop Asthma Biologics Have a Similar Risk of Asthma Exacerbations as Those Who Continue Asthma Biologics.
    Jeffery MM; Inselman JW; Maddux JT; Lam RW; Shah ND; Rank MA
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2742-2750.e1. PubMed ID: 33652135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Asthma Biologics: Implications for Patient Selection, Step Therapy, and Outcomes.
    Maddux JT; Inselman JW; Jeffery MM; Lam RW; Shah ND; Rank MA
    Chest; 2021 Mar; 159(3):924-932. PubMed ID: 33558205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry.
    Chen W; Tran TN; Sadatsafavi M; Murray R; Wong NCB; Ali N; Ariti C; Bulathsinhala L; Gil EG; FitzGerald JM; Alacqua M; Al-Ahmad M; Altraja A; Al-Lehebi R; Bhutani M; Bjermer L; Bjerrum AS; Bourdin A; von Bülow A; Busby J; Canonica GW; Carter V; Christoff GC; Cosio BG; Costello RW; Fonseca JA; Gibson PG; Yoo KH; Heaney LG; Heffler E; Hew M; Hilberg O; Hoyte F; Iwanaga T; Jackson DJ; Jones RC; Koh MS; Kuna P; Larenas-Linnemann D; Lehmann S; Lehtimäki L; Lyu J; Mahboub B; Maspero J; Menzies-Gow AN; Newell A; Sirena C; Papadopoulos NG; Papaioannou AI; Perez-de-Llano L; Perng Steve DW; Peters M; Pfeffer PE; Porsbjerg CM; Popov TA; Rhee CK; Salvi S; Taillé C; Taube C; Torres-Duque CA; Ulrik C; Ra SW; Wang E; Wechsler ME; Price DB
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2732-2747. PubMed ID: 37301430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma biologics: Real-world effectiveness, impact of switching biologics, and predictors of response.
    Abbas F; Georas S; Cai X; Khurana S
    Ann Allergy Asthma Immunol; 2021 Dec; 127(6):655-660.e1. PubMed ID: 34481992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe asthma exacerbations in the United States:: Incidence, characteristics, predictors, and effects of biologic treatments.
    Trevor J; Lugogo N; Carr W; Moore WC; Soong W; Panettieri RA; Desai P; Trudo F; Ambrose CS
    Ann Allergy Asthma Immunol; 2021 Nov; 127(5):579-587.e1. PubMed ID: 34273485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
    Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in disease burden and treatment reality in patients with severe asthma.
    Nagase H; Oka H; Uchimura H; Arita Y; Hirai T; Makita N; Tashiro N; Matsunaga K
    Respir Investig; 2024 May; 62(3):431-437. PubMed ID: 38492333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of time period to identify confounders for propensity score matching, affected the estimate: a retrospective cohort study of drug effectiveness in asthmatic children.
    Osokogu OU; Khan J; Nakato S; Weibel D; de Ridder M; Sturkenboom MCJM; Verhamme K
    J Clin Epidemiol; 2018 Sep; 101():107-115.e3. PubMed ID: 29378305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.
    Huffaker MF; Phipatanakul W
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):129-44. PubMed ID: 25459581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of asthma biologic use in a US claims database.
    Maddux JT; Inselman JW; Jeffery MM; Lam RW; Shah ND; Rank MA
    Ann Allergy Asthma Immunol; 2021 Dec; 127(6):648-654. PubMed ID: 33971361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and economic burden of severe asthma among US patients treated with biologic therapies.
    Reibman J; Tan L; Ambrose C; Chung Y; Desai P; Llanos JP; Moynihan M; Tkacz J
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):318-325.e2. PubMed ID: 33775904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS)].
    Milger K; Korn S; Feder C; Fuge J; Mühle A; Schütte W; Skowasch D; Timmermann H; Suhling H
    Pneumologie; 2023 Apr; 77(4):220-232. PubMed ID: 36796422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prediction model for asthma exacerbations after stopping asthma biologics.
    Inselman JW; Jeffery MM; Maddux JT; Lam RW; Shah ND; Rank MA; Ngufor CG
    Ann Allergy Asthma Immunol; 2023 Mar; 130(3):305-311. PubMed ID: 36509405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy.
    Schatz M; Meckley LM; Kim M; Stockwell BT; Castro M
    J Allergy Clin Immunol Pract; 2014; 2(5):570-4.e1. PubMed ID: 25213050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior authorization delays biologic initiation and is associated with a risk of asthma exacerbations.
    Dudiak GJ; Popyack J; Grimm C; Tyson S; Solic J; Ishmael FT
    Allergy Asthma Proc; 2021 Jan; 42(1):65-71. PubMed ID: 33404389
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort.
    Milger K; Suhling H; Skowasch D; Holtdirk A; Kneidinger N; Behr J; Timmermann H; Schulz C; Schmidt O; Ehmann R; Hamelmann E; Idzko M; Taube C; Lommatzsch M; Buhl R; Korn S
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2701-2712.e2. PubMed ID: 37301433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the current role of biologics in the management of patients with severe refractory asthma?
    Draikiwicz S; Oppenheimer J
    Ann Allergy Asthma Immunol; 2016 May; 116(5):383-7. PubMed ID: 27153737
    [No Abstract]   [Full Text] [Related]  

  • 18. Disease burden in patients with asthma before initiating biologics: A retrospective cohort database study.
    Ortega H; Hahn B; Tran JN; Bell C; Shams SA; Llanos JP
    Allergy Asthma Proc; 2019 May; 40(3):146-153. PubMed ID: 30925945
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
    Adir Y; Humbert M; Saliba W
    J Allergy Clin Immunol; 2021 Aug; 148(2):361-367.e13. PubMed ID: 34144110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids.
    Turner S; Richardson K; Murray C; Thomas M; Hillyer EV; Burden A; Price DB;
    J Allergy Clin Immunol Pract; 2017; 5(1):99-106.e3. PubMed ID: 27421902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.